What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
The scientist’s investigation covers issues in Immunology, Transplantation, Graft-versus-host disease, Internal medicine and Hematopoietic stem cell transplantation.
His research integrates issues of Disease and Stem cell in his study of Immunology.
His research in Transplantation intersects with topics in Homologous chromosome, CD8, Vorinostat, Leukemia and Immunotherapy.
His work in the fields of Graft-versus-host disease, such as Extracorporeal Photopheresis, intersects with other areas such as Clostridia.
Breast cancer, Prospective cohort study, Proportional hazards model and Nivolumab is closely connected to Oncology in his research, which is encompassed under the umbrella topic of Internal medicine.
His Hematopoietic stem cell transplantation study combines topics in areas such as Gastroenterology, Haematopoiesis and Predictive value of tests.
His most cited work include:
- Graft-versus-host disease (1707 citations)
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer (745 citations)
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (685 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Graft-versus-host disease, Transplantation, Internal medicine and Hematopoietic stem cell transplantation are his primary areas of study.
His studies link Disease with Immunology.
His study looks at the relationship between Graft-versus-host disease and fields such as Cancer research, as well as how they intersect with chemical problems.
His Transplantation research integrates issues from Hematopoietic cell, Leukemia, Incidence and Hazard ratio.
The Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology.
The study incorporates disciplines such as Survival rate and Transplantation Conditioning in addition to Hematopoietic stem cell transplantation.
He most often published in these fields:
- Immunology (51.43%)
- Graft-versus-host disease (37.14%)
- Transplantation (30.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (28.57%)
- Graft-versus-host disease (37.14%)
- Oncology (13.43%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Graft-versus-host disease, Oncology, Transplantation and Cell biology.
His work in the fields of Internal medicine, such as Clinical trial, Breast cancer and Cohort, overlaps with other areas such as In patient.
His Graft-versus-host disease research incorporates elements of Autophagy, ATG5, Hematopoietic stem cell transplantation and Immune system, Immunology.
He works mostly in the field of Immunology, limiting it down to topics relating to Microbiome and, in certain cases, Haematopoiesis, as a part of the same area of interest.
His work in the fields of Autologous transplantation overlaps with other areas such as Context.
His Cell biology study combines topics from a wide range of disciplines, such as T cell, Cytotoxic T cell and Secretion.
Between 2018 and 2021, his most popular works were:
- First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers. (178 citations)
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer (118 citations)
- Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Pavan Reddy mostly deals with Internal medicine, Oncology, Breast cancer, Transplantation and Clinical trial.
When carried out as part of a general Internal medicine research project, his work on Prostate cancer and Leukemia is frequently linked to work in Bone health and Context, therefore connecting diverse disciplines of study.
His Oncology research incorporates themes from Cancer, Docetaxel, MEDLINE, Guideline and Randomized controlled trial.
His study in Transplantation focuses on Autologous transplantation in particular.
Pavan Reddy has researched Clinical trial in several fields, including Acute graft versus host disease and Disease.
His Disease research includes elements of Biomarker, Serum biomarkers and Serum samples.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
